THIRD HARMONIC BIO, INC.: diluted weighted-average shares
Diluted weighted-average shares for THIRD HARMONIC BIO, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All THIRD HARMONIC BIO, INC. financial histories
What this measure means
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
Exact concept: us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2021-01-01 to 2024-12-31. The SEC response was captured on 2026-09-21.
Reading these values
This selected numerical history matches Basic weighted-average shares for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2024-01-01 | 2024-12-31 | 41,730,464 | shares | 2025-03-27 | 10-K · 0000950170-25-045736 |
| 2023-01-01 | 2023-12-31 | 39,645,392 | shares | 2025-03-27 | 10-K · 0000950170-25-045736 |
| 2022-01-01 | 2022-12-31 | 14,353,102 | shares | 2024-03-26 | 10-K · 0000950170-24-036161 |
| 2021-01-01 | 2021-12-31 | 4,043,416 | shares | 2023-03-29 | 10-K · 0000950170-23-010435 |
Related financial histories
- THIRD HARMONIC BIO, INC.: total assets
- THIRD HARMONIC BIO, INC.: total liabilities
- THIRD HARMONIC BIO, INC.: stockholders equity
- THIRD HARMONIC BIO, INC.: cash and cash equivalents
- THIRD HARMONIC BIO, INC.: net income or loss
- THIRD HARMONIC BIO, INC.: operating cash flow
- THIRD HARMONIC BIO, INC.: capital expenditure payments
- THIRD HARMONIC BIO, INC.: financing cash flow
- THIRD HARMONIC BIO, INC.: investing cash flow
- THIRD HARMONIC BIO, INC.: retained earnings or deficit
- THIRD HARMONIC BIO, INC.: basic weighted-average shares
- THIRD HARMONIC BIO, INC.: basic earnings per share
- THIRD HARMONIC BIO, INC.: diluted earnings per share
- THIRD HARMONIC BIO, INC.: net property, plant and equipment
- THIRD HARMONIC BIO, INC.: share-based compensation expense
- THIRD HARMONIC BIO, INC.: operating income or loss
- THIRD HARMONIC BIO, INC.: current assets
- THIRD HARMONIC BIO, INC.: current liabilities
- THIRD HARMONIC BIO, INC.: current accounts payable
- THIRD HARMONIC BIO, INC.: operating expenses
- THIRD HARMONIC BIO, INC.: research and development expense
Inspect the source
- Entity
- THIRD HARMONIC BIO, INC. / CIK 0001923840
- Captured
- 2026-09-21T17:34:52.194Z
- SEC response SHA-256
c1e126d325bb3ad43f0cb198ddd45e3c3fd52d56d9db931dcde21278abc2eee7
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001923840.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))